Ischemia modified albumin and carbonyl protein as potential biomarkers of protein oxidation in hemodialysis-Reference-Cited by-同舟云学术

Ischemia modified albumin and carbonyl protein as potential biomarkers of protein oxidation in hemodialysis

Published:2012-04 Issue:6 Volume:45 Page:450-454
ISSN:0009-9120
Container-title:Clinical Biochemistry
language:en
Short-container-title:Clinical Biochemistry

Author:

Albarello Kassiano,dos Santos Gélson Antônio,Bochi Guilherme Vargas,Sangoi Manuela Borges,Almeida Taís Corrêa,Paz da Silva José Edson,Garcia Solange Cristina,Moresco Rafael Noal

Publisher

Elsevier BV

Subject

Clinical Biochemistry,General Medicine

Reference55 articles.

1. Chronic kidney disease: the global challenge;Meguid El Nahas;Lancet,2005

2. Imbalance of oxidants and antioxidants in hemodialysis patients;Canaud;Blood Purif,1999

3. Polymorphonuclear leukocyte oxidative burst is enhanced in patients with chronic renal insufficiency;Ward;J Am Soc Nephrol,1995

4. Dialysis-induced oxidative stress: biological aspects, clinical consequences, and therapy;Descamps-Latscha;Semin Dial,2001

5. AOPP-induced activation of human neutrophil and monocyte oxidative metabolism: a potential target for N-acetylcysteine treatment in dialysis patients;Witko-Sarsat;Kidney Int,2003

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Independent correlation between ischemia modified albumin and parathormone in hemodialysis patients;Italian Journal of Medicine;2023-01-12

2. Independent correlation between ischemia modified albumin and parathormone in hemodialysis patients;Italian Journal of Medicine;2023-01-12

3. Renal insufficiency and chronic kidney disease – Promotor or consequence of pathological post-translational modifications;Molecular Aspects of Medicine;2022-08

4. Blood Thiol Redox State in Chronic Kidney Disease;International Journal of Molecular Sciences;2022-03-05

5. Pilot study to investigate differences in middle molecules, oxidative stress and markers of peripheral vascular disease in patients treated by high flux haemodialysis and haemodiafiltration;PLOS ONE;2021-10-06